Cell cycle arrest and apoptosis by expression of a novel TPIP (TPIP-C2) cDNA encoding a C2-domain in HEK-293 cells

Molecular Biology Reports

Volumn 39, Issue 7, 2012, Pages 7389-7402

  Mishra, Rasmi Rekha ^a   Chaudhary, Jitendra Kumar ^a   Rath, Pramod C ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Apoptosis; C2 domain; Cell proliferation; TPIP

Indexed keywords

CASPASE 3; COMPLEMENTARY DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN HEK293; COMPUTER MODEL; CONTROLLED STUDY; ENZYME ACTIVATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; MAMMAL CELL; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN PROCESSING; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TPIP C2 GENE;

AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; CELL CYCLE CHECKPOINTS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DUAL-SPECIFICITY PHOSPHATASES; HEK293 CELLS; HUMANS; MEMBRANE PROTEINS; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, SECONDARY; PTEN PHOSPHOHYDROLASE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

MAMMALIA;

EID: 84864286604     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1571-6     Document Type: Article

References (41)

1. Arena S, Benvenuti S, Bardelli A (2005) Genetic analysis of the kinome and phosphatome in cancer. Cell Mol Life Sci 62: 2092-2099 (Pubitemid 41291665)
2. Venter JC, Adams MD, Myers EW et al (2001) The sequence of the human genome. Science 291:1304-1351 (Pubitemid 32173090)
3. Myer MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94:9052-9057
4. Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phos-phatidylinositol 3, 4, 5-triphosphate. J Biol Chem 273:13375-13378 (Pubitemid 28268370)
5. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV (1997) Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:352-362
6. Li L, Ernsting BR, Wishart MJ, Lohse DL, Dixon JE (1997) A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast. J Biol Chem 272:29403-29406 (Pubitemid 27508017)
7. Jie-Oh Lee, Yang H, Georgescu M, Cristofano AD, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP (1999) Crystal structure of the PTEN tumor suppressor: implications for its phos-phoinositide phosphatase activity and membrane association. Cell 99:323-334 (Pubitemid 29519911)
8. Adey NB, Huang L, Ormonde PA, Baumgard ML, Pero R, Byreddy DV, Tavtigian SV, Bartel PL (2000) Threonine phos-phorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. Cancer Res 60:35-37 (Pubitemid 30058725)
9. Cully M, You H, Levine AJ, Mak TW (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6:184-192 (Pubitemid 43292562)
10. Wang X, Jiang X (2008) PTEN: a default gate-keeping tumor suppressor with a versatile tail. Cell Res 18:807-816
11. Lee JJ, Kim BC, Park MJ, Lee YS, Kim YN, Lee BL, Lee JS (2011) PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation. Cell Death Differ 18:666-677
12. Lehman JA, Waning DL, Batuello CN, Cipriano R, Kadakia MP, Mayo LD (2011) Induction of apoptotic genes by a p73-PTEN complex in response to genotoxic stress. J Biol Chem 286: 36631-36640
13. Walker SM, Downes CP, Leslie NR (2001) TPIP: a novel phosphoinositide 3-phosphatase. Biochem J 360:277-283 (Pubitemid 33151322)
14. Tapparel C, Reymond A, Girardet C, Guillou L, Lyle R, Lamon C, Hutter P, Antonarakis SE (2003) The TPTE gene family: cellular expression, subcellular localization and alternative splicing. Gene 323:189-199 (Pubitemid 37501099)
15. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A (2004) Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303:1179-1181 (Pubitemid 38233580)
16. Georgescu MM, Kirsch KH, Kaloudis P, Yang H, Pavletich NP, Hanafusa H (2000) Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res 60:7033-7038 (Pubitemid 32059181)
17. Das S, Dixon JE, Cho W (2003) Membrane-binding and activation mechanism of PTEN. Proc Natl Acad Sci USA 100:7491-7496 (Pubitemid 36759997)
18. Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128:157-170 (Pubitemid 46048887)
19. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, Haug JS, Rupp D, Porter-Westpfahl KS, Wiedemann LM, Wu H, Li L (2006) PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441:518-522 (Pubitemid 44050154)
20. Vazquez F, Ramaswamy S, Nakamura N, Sellers WR (2000) Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20:5010-5018 (Pubitemid 30431555)
21. Leslie NR, Yang X, Downes CP, Weijer CJ (2007) PtdIns(3, 4, 5)P3-dependent and independent roles for PTEN in the control of cell migration. Curr Biol 17:115-125 (Pubitemid 46107842)
22. Meuillet EJ, Mahadevan D, Berggren M, Coon A, Powis G (2004) Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys 429:123-133 (Pubitemid 39093822)
23. Mehenni H, Lin-Marq N, Buchet-Poyau K, Reymond A, Collart MA, Picard D, Antonarakis SE (2005) LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Hum Mol Genet 14:2209-2219 (Pubitemid 41418020)
24. Tang Y, Eng C (2006) PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner. Cancer Res 66:736-742 (Pubitemid 43165936)
25. Bajaj GD (2002) Molecular cloning and characterization of human cDNAs by a simple repeat DNA probe: identification of novel candidate genes, PhD thesis, School of Life Sciences, Jawaharlal Nehru University, New Delhi
26. Dey I, Rath PC (2005) A novel rat genomic simple repeat DNA with RNA-homology shows triplex (H-DNA)-like structure and tissue-specific RNA expression. Biochem Biophys Res Commun 327:276-286 (Pubitemid 40051381)
27. Maiti R, Domselaar GHV, Zhang H, Wishart DS (2004) SuperPose: a simple server for sophisticated structural superposition. Nucleic Acids Res 32:W590-W594 (Pubitemid 38997404)
28. Huang H, Cheville JC, Pan Y, Roche PC, Schmidt LJ, Tindall DJ (2001) PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. J Biol Chem 276:38830-38836
29. Kotamraju S, Konorev EA, Joseph J, Kalyanaraman B (2000) Doxorubicin-induced apoptosis in endothelial cells and cardio-myocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem 275: 33585-33592
30. Linding R, Russell RB, Neduva V, Gibson TJ (2003) GlobPlot: exploring protein sequences for globularity and disorder. Nucleic Acids Res 31:3701-3708 (Pubitemid 37442227)
31. Odriozola L, Singh G, Hoang T, Chan AM (2007) Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J Biol Chem 282:23306-23315 (Pubitemid 47311930)
32. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M (1999) Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274:22932-22940
33. Mishra RR, Chaudhary JK, Bajaj GD, Rath PC (2011) A novel human TPIP splice-variant (TPIP-C2) m RNA, expressed in human and mouse tissues, strongly inhibits cell growth in HeLa cells. PLoS ONE 6(12):e28433. doi:10.1371/journal. pone. 0028433
34. 2+-binding domain. J Biol Chem 273:15879-15882 (Pubitemid 28311347)
35. Shao C, Novakovic VA, Head JF, Seaton BA, Gilbert GE (2008) Crystal structure of lactadherin C2 domain at 1.7A resolution with mutational and computational analyses of its membrane-binding motif. J Biol Chem 283:7230-7241
36. Gustafson S, Zbuk KM, Scacheri C, Eng C (2007) Cowden syndrome. Semin Oncol 34:428-434 (Pubitemid 47503276)
37. Yeo EJ, Ryu JH, Chun YS, Cho YS, Jang IJ, Cho H, Kim J, Kim MS, Park JW (2006) YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases. Cancer Res 66: 6345-6352
38. Gan YH, Jhang S (2009) PTEN/AKT pathway involved in his-tone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. Oral Oncol 45:e150-e154
39. Lu K, Li P, Zhang M, Xing G, Li X, Zhou W, Bartlam M, Zhang L, Rao Z, He F (2011) Pivotal role of the C2 domain of the smurf1 ubiquitin ligase in substrate selection. J Biol Chem 286:16861-16870
40. Cabarcas S, Watabe K, Schramm L (2010) Inhibition of U6 snRNA Transcription by PTEN. Online J Biol Sci 10:114-125
41. Law RH, Lukoyanova N, Voskoboinik I, Caradoc-Davies TT, Baran K, Dunstone MA, D'Angelo ME, Orlover EV, Coulibaly F, Verschoor S, Browne KA, Ciccone A, Kuiper MJ, Bird PI, Tra-pani JA, Saibil HR, Whisstock JC (2010) The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 468:447-451